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Oxidative stress is regarded as a mediator of nerve cell death in 
several  neurodegenerative  disorders,  such  as  Parkinson’s  disease. 
Sesamin,  a  lignan  mainly  found  in  sesame  oil,  is  currently 
under  study  for  its  anti-oxidative  and  possible  neuroprotective 
properties.  We  used  1-methyl-4-phenyl-pyridine  (MPP+)  ion, 
the  active  metabolite  of  the  potent  parkinsonism-causing  toxin 
1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine,  to  produce  oxida-
tive stress and neurodegeneration in neuronal PC12 cells, which 
express  dopamine,  as  well  as  neurofilaments.  Our  results  show 
that  picomolar  doses  of  sesamin  protected  neuronal  PC12  cells 
from  MPP+-induced  cellular  death,  as  revealed  by  colorimetric 
measurements and production of reactive oxygen species. We also 
demonstrated that sesamin acted by rescuing tyrosine hydroxylase 
levels from MPP+-induced depletion. Sesamin, however, did not 
modulate dopamine transporter levels, and estrogen receptor-alpha 
and -beta protein expression. By examining several parameters of 
cell distress, we found that sesamin also elicited a strong increase 
in superoxide dismutase activity as well as protein expression and 
decreased  catalase  activity  and  the  MPP+  stimulated  inducible 
nitric oxide synthase protein expression, in neuronal PC12 cells. 
Finally, sesamin possessed significant anti-inflammatory properties, 
as disclosed by its potential to reduce MPP+-induced interleukin-6 
mRNA levels in microglia. From these studies, we determined the 
importance of the lignan sesamin as a neuroprotective molecule 
and its possible role in complementary and/or preventive therapies 
of neurodegenerative diseases.
Introduction
A large body of experimental evidence supports a role for oxida-
tive stress as mediator of nerve cell death in several neurodegenerative 
disorders,  such  as  Parkinson  disease  (PD).  The  degeneration  of 
dopaminergic (DAergic) neurons located in the substantia nigra char-
acterizes PD and leads to a decline of dopamine (DA) as well as its 
biosynthetic enzyme, tyrosine hydroxylase (TH), and its high-affinity 
cellular transporter (DAT). As reported recently, apoptotic death of 
DA neurons may be initiated by oxidative stress and neuroinflam-
mation.1-3 Besides, elevated iron levels, decreased glutathione levels, 
impaired mitochondrial complex 1 activity and increased superoxide 
dismutase (SOD) activity have been observed in PD brains.4-6
1-Methyl-4-phenyl-1,2,5,6-tetrahydropyridine  (MPTP)  is  a 
neurotoxin that causes Parkinson-like symptoms in humans, monkeys 
and mice.7-9 This toxin is largely employed as an experimental model 
to  study  therapeutic  strategies  against  PD.  1-Methyl-4-phenyl-
pyridine ion (MPP+), the active metabolite of MPTP, is selectively 
taken  up  in  DAergic  neurons  by  DAT  and  actively  transported 
into the mitochondria where it interferes with the respiratory chain 
and inhibits complex 1, inducing energy depletion and producing 
reactive  oxygen  species  (ROS),  such  as  superoxide  anions.10,11 
Superoxide anions can react with nitric oxide (NO) to produce the 
potent oxidant peroxynitrite, which has been implicated in the devel-
opment of many neurological diseases.1,12,13 To date, however, the 
precise mechanism of MPP+-induced ROS generation is still under 
discussion.13
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1 pM sesamin on MPP+-induced neuronal death. Figure 1 shows 
significant  cell  death  after  24-h  exposure  to  MPP+.  Pretreatment 
with 10-12 M sesamin prior to the production of oxidative stress 
greatly attenuated MPP+ toxicity in neuronal PC12 cells. Specifically, 
sesamin protected neuronal PC12 cells against MPP+ by reducing 
MPP+-evoked  cellular  death  by  60%.  Figure  2  illustrates  the 
rhodamine  detection  of  ROS  in  neuronal  PC12  cells. The  non-
flourescent dye DHR was converted to rhodamine in the presence of 
ROS.31,34,35 Figure 2A shows low levels of rhodamine fluorescence 
in control neuronal PC12 cells as well as in cells treated with sesamin 
alone, after 24 h (Fig. 2A, CTRL and sesamin, respectively), whereas 
On the other side, sesamin, a phytonutrient of the class of lignans, 
is a lipophilic compound found in sesame seeds and sesame seed oil 
and is known for its antioxidant role.14-16 Sesamin as well as sesamol 
and sesaminol, the other 2 primary compounds in sesame, are likely 
responsible  for  the  increased  stability  of  sesame  oil  against  auto-
oxidation and the development of rancidity caused by free radicals.17 
Indeed, sesamin is recognized to have several positive physiological 
effects, such as hypocholesterolemic,18 antihypertensive actions,19-21 
and regulates lipid and alcohol metabolism in the liver.22 It is also 
known  to  protect  against  rotenone-induced  loss  of  DA  cells  in 
mice23 and to inhibit lipopolysaccharide (LPS)-mediated activation 
of microglial cells in vitro.24
In this study, we investigated the neuroprotective, antioxidative 
and anti-inflammatory actions of sesamin in a model of DA neurons, 
neuronal PC12 cells.25,26 MPP+ was used to induce oxidative damage 
in these cells and stimulate pro-inflammatory cytokine production in 
the microglial cells line N9.27,28 Our results show that picomolar 
doses of sesamin protect neuronal PC12 cells from oxidative stress 
by reducing MPP+-evoked cellular death and by decreasing ROS 
production. Moreover, sesamin restores TH protein expression after 
MPP+-induced reduction without modulating DAT protein levels. 
Our data also reveal that sesamin increases SOD activity and SOD 
protein  production  as  well  as  diminishes  catalase  (CAT)  activity, 
indicating a rescue role for sesamin in the oxidative metabolism of 
DA neurons. Finally, our study demonstrates that sesamin decreases 
inducible NO synthase (iNOS) protein expression in neuronal cells 
and lowers mRNA levels of the potent pro-inflammatory cytokine 
interleukin-6 (IL-6) in microglial cells. In this comprehensive study, 
we outline the importance of the lignan sesamin as a neuroprotective 
molecule and its possible potential in complementary and/or preven-
tive therapies of neurodegenerative diseases.
 Results
Sesamin reduces MPP+-induced cytotoxicity and MPP+ produc-
tion of ROS. We measured the protective effect of pretreatment with 
Figure 1. Effect of sesamin on MPP+-induced toxicity, as revealed by measur-
ing LDH activity in supernatants after 24 h of treatment. Neuronal cells were 
pretreated with 10–12 M sesamin for 3 h, and then MPP+ was added for 24 
h. The control medium was subtracted from all absorbance measurements, as 
described in Materials and Methods. n = 6. **p < 0.01 and ***p < 0.001 
vs. sesamin alone; ooop < 0.001 vs MPP+.
Figure 2. Rhodamine detection of ROS within neuronal PC12 cells. DHR is 
oxidized to fluorescent rhodamine in the presence of ROS. (A) Fluorescence 
microphotographs,  Ctrl:  cells  were  treated  with  vehicle.  Sesamin:  cells 
were treated with 10–12 M sesamin. MPP+: cells were treated with 5 mM. 
Sesamin  +  MPP+:  cells  were  pretreated  with  sesamin  for  3  h  and  then 
MPP+ was administered. A marked signal is evident only in neuronal PC12 
cells  treated  with  MPP+  but  not  in  those  treated  with  medium  (CTRL)  or 
sesamin alone. (B) Semi-quantitative image analysis. Fluorescent units (F.U.). 
Magnification x 400. n = 3. ***p < 0.001 vs CTRL or sesamin alone; ooop 
< 0.001 vs. MPP+.Neuroprotective effects of sesamin
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Sesamin  rescues  TH  protein  expression  without  modulating 
DAT  protein  level.  TH  is  the  rate-limiting  enzyme  for  DA 
production. TH  protein  expression  was  decreased  after  treatment 
with MPP+, whereas sesamin alone did not modulate it (Fig. 5A). 
Interestingly, when the cells were co-treated with MPP+ and sesamin, 
a slight but constant increase in TH protein expression was mani-
fested, suggesting a neuroprotective role for sesamin in DA neurons. 
Figure 5B depicts that DAT protein levels were downregulated by 
MPP+,  as  already  reported,25,26  and  they  were  not  impacted  by 
sesamin  alone.  Pretreatment  with  sesamin  before  MPP+  caused 
a slight decline in DAT protein levels which was not statistically 
significant in comparison to MPP+ values. 
Sesamin does not modulate ERα or ERβ protein expression. 
MPP+ administration did not influence ERα or ERβ protein expres-
sion in neuronal PC12 cells, as already demonstrated.25,26 Sesamin, 
alone or in combination with MPP+, also did not alter ERα or ERβ 
protein expression (Fig. 6A and B, and Fig. 6C and D, respectively), 
indicating that the intracellular actions of sesamin do not involve 
the  nuclear  ERs.  Interestingly,  immunofluorescence  also  revealed 
the  cytoplasmic  and  nuclear  localization  of  ERα,  whereas  ERβ 
appeared to be localized exclusively in the cytoplasm (Fig. 6B and 
D, respectively).
Sesamin  modulates  iNOS  protein  expression.  Western  blot-
ting quantified the protein expression of iNOS, the enzyme mainly 
responsible for NO synthesis. Molecules that can inhibit iNOS may 
have anti-inflammatory activity. Figure 7 shows that when neuronal 
PC12 cells were exposed to MPP+, iNOS production was augmented 
as expected and already demonstrated.37 In Figure 7, we also report 
that sesamin alone reduced iNOS production and that its adminis-
tration prior to MPP+ provoked a marked decrease of MPP+-induced 
iNOS production, sustaining a scavenging role of sesamin against 
reactive nitrogen species. 
a marked signal was detected in MPP+-treated neuronal cells (Fig. 2A, 
MPP+). On the other hand, cells treated with sesamin prior to MPP+ 
demonstrated a dampened signal in comparison to MPP+ alone (Fig. 
2A, sesamin + MPP+), suggesting a scavenging action of sesamin 
on MPP+-induced oxidative stress. Figure 2B reports on the semi-
quantitative analysis of rhodamine fluorescence presented in figure 
2A, revealing high-level fluorescence in the presence of MPP+ and a 
very significant reduction (p < 0.001) when the neuronal cells were 
pretreated with sesamin prior to MPP+.
Effect of sesamin on MPP+-induced increase in SOD and CAT 
activity. We used tetrazolium salt to detect superoxide radicals, as 
described  in  Materials  and  Methods.  If  SOD  was  present  in  the 
sample, the superoxide radicals would be dismutated by the enzyme. 
Figure 3 illustrates that sesamin alone increased SOD activity (Fig. 
3A). Interestingly, sesamin also heightened SOD protein expression 
(Fig. 3B) in the same experimental paradigm, as revealed by Western 
blot analysis, indicating a shielding role for sesamin in pretreatment 
experiments. Our results also show that MPP+ increased both SOD 
and CAT activities, confirming a cellular response to MPP+ produc-
tion of ROS (Fig. 2), as demonstrated in vivo.36 When sesamin was 
administered prior to MPP+, we still detected an increment of SOD 
activity  compared  to  the  control  condition  (Fig.  3A).  However, 
we did not observe any statistically-significant difference in SOD 
activity compared to MPP+ levels. Figure 4A reveals that sesamin 
alone decreased CAT activity and Fig 4B shows no apparent modula-
tion of CAT protein expression. More importantly, sesamin reduced 
the MPP+-induced increase in CAT activity (Fig. 4A) when adminis-
tered prior to MPP+, supporting an anti-oxidant role for sesamin in 
MPP+-treated cellular systems.
Figure 3. SOD activity (A) and SOD protein expression (B). (A) Sesamin 
markedly increased SOD activity in our experimental conditions. MPP+ also 
upregulated SOD activity by generating superoxide ions. SOD activity levels 
were increased over control values when sesamin was administered prior to 
MPP+. (B) Western blots indicate increased SOD protein expression when 
sesamin was added to the medium in neuronal PC12 cells. ***p < 0.001 
and *p < 0.05 vs CTRL; oop<0.01 vs. MPP+; MPP+ vs. sesamin + MPP+ is 
nonsignificative (NS)
Figure 4. CAT activity (A) and CAT protein expression (B). (A) CAT activity was 
significantly reduced in the presence of sesamin whereas it was increased 
when MPP+ was administered. Treatment of neuronal PC12 cells with sesamin 
prior to MPP+ reduced MPP+-induced CAT activity levels. (B) Western blots. 
**p < 0.01 and vs CTRL; oop < 0.01 and ooop < 0.001 vs. MPP+.Neuroprotective effects of sesamin
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of oxidative stress and neuroprotection of DA neurons.25,42 After 
NGF administration, PC12 cells differentiate into the neuronal-like 
phenotype  that  secretes  high  DA  levels  and  expresses TH,  DAT, 
neurofilaments as well as ERα and ERβ.25,43-46 It has already been 
demonstrated  that  various  natural  molecules  exert  anti-oxidative 
actions on mammalian cells, but these effects often require micro-
molar concentrations which would likely be impossible to sustain 
in vivo in humans due, in part, to the rapid metabolism of these 
phytonutrients.47-49 In this study, we examined the neuroprotective, 
antioxidant  and  anti-inflammatory  consequences  of  low  doses  of 
sesamin (10-12 M), the major component of sesame oil. The positive 
outcomes we reported in neuronal culture, using picomolar doses 
of sesamin on parameters of neuroprotection, oxidative metabolism 
and neuroinflammation, are supported by the fact that sesamin is 
likely to accumulate in serum and in the brain, being less suscep-
tible to conjugation in the liver.50 In particular, we demonstrated 
that picomolar doses of sesamin can protect DA neuronal cells from 
MPP+-induced cellular death by reducing intracellular ROS produc-
tion. Indeed, non-fluorescent DHR has the capacity to enter cells 
and, once in, it is oxidized by oxygen species (superoxide anion, 
peroxynitrite) in fluorescent rhodamine.35 Accordingly, our results 
show increased rhodamine fluorescence after MPP+ treatment and 
reduced  fluorescence  when  sesamin  is  administered  to  neuronal 
PC12 cells prior to MPP+.
Currently,  many  clues  point  to  the  involvement  of  oxidative 
stress in the pathogenesis of PD (reviewed in refs. 51 and 52). On 
the one hand, it is now also recognized that estrogen replacement 
therapy in postmenopausal women reduces the risk of neurodegen-
erative diseases, particularly PD,53 possibly because the antioxidant 
properties of estrogens contribute to their neuroprotective actions. 
Nevertheless, clinical trials have raised growing concern about the 
secondary hormonal outcomes of hormone replacement therapy.54 
Yet, phytoestrogens are naturally-occurring molecules that may exert 
neuroprotective effects similar to those of estrogens25,55,56 and have 
lesser hormonal actions. In our study, sesamin did not modulate ERα 
or ERβ, making it unlikely that these nuclear receptors are involved 
in its neuroprotective outcomes.
MPTP has been widely used as a DA neurotoxin because it causes 
a severe Parkinson-like syndrome in humans, monkeys and mice.7-9 
MPTP can produce oxidative stress in neurons by various mecha-
nisms. ROS are generated during MPTP metabolism to MPDP and 
then to MPP+, by monoamino oxidase B in astrocytes. Moreover, 
massive DA release after MPP+/MPTP administration evokes exces-
sive amounts of H2O2, resulting in oxidative stress. MPP+ can also 
elicit ROS release through the inhibition of mitochondrial respira-
tion by impairing Na+/K+-ATPase function and leading to neuronal 
depolarization.11,57 Then, the levels of TH protein, the DA key chain 
metabolic enzyme, are reduced in vivo after MPTP administration.58 
Our present findings demonstrated prevention of the MPP+-induced 
decline  in  TH  expression  when  sesamin  was  administered  prior 
to  MPP+,  indicating  a  neuroprotective  action  of  sesamin  in  DA 
neurons. Besides, we did not detect any modulation of DAT protein 
levels by sesamin, yet a specific effect of sesamin on TH expression 
was sustained. This is significant since DAT exerts its critical func-
tion by transporting DA into presynaptic cells; thus, molecules or 
pathologies that disrupt DAT could have a profound impact on the 
behaviors and physiological conditions it mediates.59,60 DAT is also 
Sesamin diminishes MPP+-induced IL-6 mRNA in microglial 
cells.  By  RT-qPCR,  we  measured  the  expression  of  the  potent 
pro-inflammatory cytokine IL-6. Figure 8 shows that MPP+ induced 
the activation of N9 microglial cells by dramatically increasing IL-6 
mRNA levels. When sesamin was administered alone, no IL-6 was 
detectable, whereas the pretreatment of neuronal PC12 cells with 
sesamin 3 h before MPP+ elicited a reduced pattern of IL-6 gene 
expression, suggesting sesamin’s significant anti-inflammatory role.
 Discussion
A growing body of literature is reporting a positive association 
between the consumption of foods and beverages containing high 
levels  of  natural  antioxidants  and  the  prevention  of  several  age-
dependent diseases, such as cancer, stroke, osteoporosis and coronary 
heart disorders38 as well as Alzheimer’s disease,39,40 opposite to the 
effects of high-calorie diets.41 In this study, we tested neuronal PC12 
cells, a known, reliable and efficient paradigm for the investigation 
Figure  5.  TH  protein  expression  (A)  and  DAT  protein  expression  (B). 
(A) Sesamin did not modulate TH expression when used alone in neuronal 
PC12 cells. When it was administered prior to MPP+, a slight but constant 
increase of TH protein expression was apparent. (B) Western blots revealed 
that  sesamin  did  not  modulate  DAT  protein  levels.  MPP+  decreased  DAT 
levels. We could not detect any statistically-significant variation when the 
cells  were  pretreated  with  sesamin  before  MPP+  administration.  ***p  < 
0.001 and *p < 0.05 vs CTRL; op < 0.05 vs. MPP+; MPP+ vs. sesamin + 
MPP+ is nonsignificative (NS).Neuroprotective effects of sesamin
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Figure 6. ERα (A and B) and ERβ (C and D) protein expression, as revealed by immunofluorescence in neuronal PC12 cells. No statistically-significant dif-
ference of ERα or ERβ protein expression was observed after each treatment. Microfluorescence panels (A and C): ERα and ERβ proteins as revealed by 
monoclonal antibodies (red staining with Cy3); nuclei were coloured blue with DAPI, as described in Materials and methods. Histograms (B and D): semi-
quantitative analysis of the fluorescent signal shown above. CTRL, sesamin alone, MPP+, MPP+ + sesamin in both panels. Magnification x 400. 
Figure 7. iNOS protein expression as revealed in neuronal PC12 cells after 
sesamin  and  MPP+  administration.  10–12  M  sesamin  slightly  decreased 
iNOS protein expression and MPP+ markedly increased iNOS protein levels 
in our cellular paradigm. When sesamin was administered prior to MPP+ 
a significant decline of iNOS was detected. **p < 0.01 vs CTRL; ooop < 
0.001 v.s MPP+.
Figure 8. IL-6 mRNA levels shown by RT-qPCR. N9 microglia cells were first 
treated or not with sesamin for 3 h, then MPP+ was added or not. MPP+ 
clearly induced a significant increase of IL-6 mRNA levels, but when micro-
glial cells were treated with sesamin prior to MPP+, we detected a significant 
decline of IL-6 mRNA. n = 3. ***p < 0.001 vs CTRL, oop < 0.01 vs MPP+.Neuroprotective effects of sesamin
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apoptosis-inducer, and iNOS is a key enzyme in charge of producing 
large NO quantities. Sesamin and sesamin metabolites are known to 
induce endothelial NOS and thus playing an important anthyper-
tensive function.19,21 In this study, we demonstrated that sesamin 
markedly reduced the MPP+-induced upregulation of iNOS expres-
sion,  corroborating  other  data  on  similar  effects  of  curcumin  in 
PC12 cells.70
Finally, microglia activation and neuroinflammation have been 
proposed  as  candidates  that  mediate  the  apoptotic  cell  death  of 
DA  neurons.  Currently,  various  phytonutrients,  such  as  resvera-
trol,  quercetin,  silymarin,  epigallocatechin-3-gallate  and  sesamin, 
have been found to dampen microglial activation in vitro and in 
vivo.71-74 Others report that sesamin inhibits LPS-mediated activa-
tion of microglial cells in vitro24,75 as well as iNOS mRNA levels.76 
MPTP has recently been reported to activate microglia in vivo,27,77 
and  to  induce  TNFα  expression.78  Pro-inflammatory  cytokines, 
identified in the post-mortem substantia nigra, striatum, and cere-
brospinal fluid of PD patients, include TNFα, IL-1β, -2 and -6 and 
interferon-gamma.79,80 We studied the N9 microglial cell line to 
quantitatively analyze mRNA levels of the potent pro-inflammatory 
cytokine IL-6. Our results are the first to quantitatively indicate that 
sesamin can indeed reduce mRNA IL-6, when the inflammation 
process is induced by MPP+, supporting a complex role of sesamin 
in the mechanisms of neuroprotection, both at the neuronal and 
glial levels.
In conclusion, our comprehensive findings point to a distinct role 
of the sesame lignan sesamin as a potent neuroprotective antioxidant 
and anti-inflammatory agent. Certainly, cellular studies on natural 
compounds  that  could  restore  damaged  mitochondrial  functions 
and interfere with the production of ROS and NOS could benefit 
complementary  alternative  medicine  and  preventive  therapies  of 
neurodegenerative diseases.
Materials and Methods
Materials. All reagents were purchased from Sigma (St. Louis, 
MO) unless noted otherwise.
Cell  culture  and  treatments.  PC12  cells  (ATCC,  Rockville, 
MD) were maintained in a controlled environment at 37˚C and in 
5% CO2 atmosphere. They were grown in RPMI-1640 medium, 
without  phenol  red,  supplemented  with  5%  fetal  bovine  serum 
(FBS), 10% horse serum (HS, Invitrogen, Toronto, ON, Canada) 
and gentamicin (50 µg/ml). The culture medium was changed every 
3 days. For each experiment, cellular density was 30,000 cells/cm2. 
Neuronal differentiation was induced for 8 days by 50 ng/ml nerve 
growh  factor  (NGF)  in  RPMI-1640  medium  supplemented  with 
1% FBS, as already described.25 To examine the effect of sesamin on 
MPP+-evoked oxidative stress, the cells were pretreated with sesamin 
(1 pM) for 3 h and then exposed to MPP+ (5 mM) for 24 h.25 
This concentration of sesamin was chosen as the lowest dose able 
to rescue cells from MPP+-induced cellular death, after kinetic and 
dose-response studies (data not shown). The microglial cell line N9 
(a generous gift from Dr. L. Vallières, Centre de recherche, CHUL, 
Quebec, QC, Canada) was grown in 10% HS in Dulbecco’s modi-
fied Eagle’s medium-F12-ham (DMEM-F12). To assess the influence 
of  sesamin  on  MPP+-induced  N9  inflammation,  the  cells  were 
pretreated with sesamin for 3 h and then exposed to MPP+ (500 µM) 
for 24 h. All experiments were performed in phenol red-free medium 
known to be sensitive to inhibition by ROS and possibly by NOS.13 
Our results showing reduced DAT protein levels after MPP+ admin-
istration  confirm  previous  data.26  However,  in  our  experiments, 
we could not demonstrate the recovery of DAT protein expression 
when sesamin was given prior to MPP+, indicating no acting defense 
of sesamin against MPP+-induced damage. Alternatively, the pico-
molar doses of sesamin we tested were not sufficient to specifically 
modulate DAT expression against the relatively high doses of MPP+ 
we used. These relatively high doses of MPP+ were required in our 
cellular paradigm as well as in others61,62 to reach significant cellular 
death over a short time period.
We  also  analyzed  the  effects  of  sesamin  on  parameters  of  cell 
distress as well as markers of neuroinflammation. Indeed, increased 
iron  levels,  decreased  glutathione  levels,  impaired  mitochondrial 
complex 1 activity and heightened SOD activity have been observed 
in PD brains.4-6 Moreover, the apoptotic death of DA neurons may 
be initiated by oxidative stress and neuroinflammation.2,3 In vivo 
studies suggest that sesamin protects the liver against Fe-induced 
oxidative damage by decreasing liver enzyme activities involved in 
lipogenesis and by increasing those implicated in fatty acid oxida-
tion.63,64 Other recent data report that dietary sesame seed increase 
the levels of vitamin C and E, two antioxidative vitamins, in various 
tissues.65
Augmented SOD activity demonstrates that sesame lignans may 
enhance the ability to eliminate superoxide radicals formed during 
Fe2+-induced  oxidative  stress.14  Accordingly,  we  found  increased 
SOD activity as well as SOD protein expression when sesamin was 
administered alone in the medium, indicating a protective role in 
pretreatment  experiments.  In  addition,  several  other  natural  and 
synthetic molecules are reported to heighten SOD activity in various 
cellular  systems.66-68  MPP+  also  augmented  SOD  activity  in  our 
experiments,  as  described  in  the  recent  literature  where  MPTP 
increased  SOD  activity  by  generating  superoxide  ions.36  In  our 
experimental conditions, pretreatment with sesamin prior to MPP+ 
administration  elevated  SOD  activity  in  comparison  to  control 
cells, but this was similar to SOD activity after MPP+ treatment. 
The  apparent  contrasting  action  of  SOD  should  be  analyzed  by 
comparing it with the results obtained by fluorescent rhodamine. 
Indeed, low ROS levels, illustrated by low rhodamine fluorescence 
(sesamin alone and sesamin + MPP+), sustained the ability of sesamin 
to induce SOD activity and protein expression, as demonstrated by 
our data. When MPP+ was administered, rhodamine fluorescence 
indicated high ROS levels and, consequently, the cells responded 
by augmenting SOD activity, as already reported.36 Our findings 
clearly show that SOD activity may be induced by 2 different mecha-
nisms, a protective mechanism and a response-to-stress mechanism. 
Pretreatment with sesamin prior to MPP+ administration indicates 
low ROS levels, as revealed by rhodamine fluorescence, and suggests 
that the SOD activity induced by sesamin pretreatment may scavenge 
MPP+-generated ROS. However, other data are needed to determine 
the balance between sesamin- and MPP+-induced SOD activity. 
CAT  activity  is  another  parameter  of  oxidative  stress.  Our 
results  showed  that  sesamin  decreased  CAT  activity  and  sesamin 
pretreatment reduced the MPP+ -induced increase in CAT activity, 
confirming a scavenging role for sesamin in the pretreatment experi-
mental condition. 
To date, ROS can no longer be regarded as the sole damaging 
species in MPTP/MPP+-induced toxicity.13,69 Certainly, NO is an Neuroprotective effects of sesamin
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(Santa  Cruz  Biotechnology,  Santa  Cruz,  CA),  anti-Cu/Zn  SOD 
antibody  (1:1000)  (StressMarq,Victoria,  BC,  Canada),  anti-CAT 
antibody (1: 50) (Santa Cruz Biotechnology), and anti-iNOS anti-
body (1:50) (StressGene, Biotech, Ann Arbor, MI). The following 
day, the membranes were washed, and anti-mouse POD-conjugated 
secondary  antibody  diluted  1:10,000  was  added  for  1  h  at  RT. 
Immunopositive  signals  were  visualized  by  enhanced  chemilumi-
nescence with the AlphaEase FC imaging system (Alpha Innotech, 
San Leandro, CA) and analyzed with AlphaEase FC software (Alpha 
Innotech).
Immunofluorescence.  Neuronal  PC12  cells  were  plated  on 
collagen-coated coverslips in 24-well plates and neuronal differen-
tiation was induced for 8 days with NGF, as described above. After 
treatment, the cells were fixed in 4% paraformaldehyde for 1 h at 4°C, 
then permeabilized with fish skin gelatin buffer + Triton (TBS, 1% 
BSA, 0.18% fish skin gelatin, 0.1% Triton-X, 0.02% sodium azide) 
for 30 min at RT. The fixed cells were incubated with monoclonal 
anti-estrogen  receptor-alpha  (ERα)  antibody  (StressGene)  diluted 
1:500, for 2 h at RT or with polyclonal anti-ERβ antibody (Santa 
Cruz Biotechnology) diluted 1:50, for 2 h at RT. Then, the slides 
were washed with PBS and stained with Cy3-conjugated secondary 
antibody (Medicorp, Montreal, QC, Canada) diluted 1:500, for 2 h 
at RT. Finally, 4’,6-diamidino-2-phenylindole (DAPI, 5 µg/ml) was 
added for 10 min at 37˚C to counterstain all nuclei. Coverslips were 
mounted with a Molecular Probes Prolong Antifade Kit (Invitrogen). 
Images were acquired with an Orthoplan fluorescence microscope 
(Leica)  with  a  high-pressure  mercury  burner  and  necessary  filter 
cubes, then analyzed with NIS-Element 2.2 software (Nikon).
Real time-quantitative polymerase chain reaction (RT-qPCR). 
Total RNA was extracted with Sigma’s GenElute Mammalian Total 
RNA  extraction  kit.  RNA  was  spectrophotometrically  measured 
for each condition, and 1 µg of total RNA was reverse-transcribed 
with 25 U of M-MULV reverse transcriptase, 1.5 µM dNTP, and 
10 µM of random hexamers. RT-qPCR was then performed in a 
MiniOpticon Real-time PCR system (BioRad) in 20 µl-sized reac-
tions containing 4 µl of the cDNA mixture, 0.3 µM of each forward 
and reverse primer and 10 µl of iQ SYBR Green Supermix (BioRad). 
Incubation at 95°C for 3 min was followed by 40 cycles of 15 s 
at 95°C and 30 s at 61°C. Primers for tumor necrosis factor-beta 
(TNFβ) (5’-CAC GAG GTC CAG CTC TTT TC-3’ and 5’-AGT 
GCA  AAG  GCT  CCA  AAG  AA-3’),  IL-6  (5’-TTC  CAT  CCA 
GTT GCC TTC TT-3’ and 5’-ATT TCC ACG ATT TCC CAG 
AG-3’), Ubiquitin C (5’-AGC CCA GTG TTA CCA CCA AG-3’ 
and 5’-TCA CAC CCA AGA ACA AGC AC-3’), β-microglobulin 
(5’-ATG GGA AGC CGA ACA TAC TG-3’ and (5’-CAG TCT 
CAG TGG GGG TGA AT-3’) were synthesized at Sigma Genosys 
(Oakville,  ON,  Canada).  Reactions  were  performed  in  duplicate, 
and 3 independent preparations of cDNA were studied. A 10-fold 
dilution series was obtained from a random pool of cDNA ranging 
from x10 to x100,000 dilution. Mean cycle threshold values (Ct) for 
each dilution were plotted against log10 of cDNA input to generate 
efficiency plots. The reaction efficiency for each gene assay was calcu-
lated according to the following equation:
E = 10(-1/slope)
and charcoal-stripped serum to remove steroids from the medium.
Cytotoxicity measurements. Cytotoxicity was evaluated by colo-
rimetric assay (Roche Diagnostics, Laval, QC, Canada) based on the 
measurement of lactate dehydrogenase (LDH) activity released from 
damaged cells into the supernatant, as already described in refer-
ence 25. LDH is a stable cytoplasmic enzyme present in all cells. It 
is rapidly released into the cell culture supernatant upon damage of 
the plasma membrane. The amount of enzyme activity detected in 
the culture supernatant correlates with the portion of lysed cells.29,30 
Briefly, 100 μl of cell-free supernatant were taken to quantify LDH 
activity by measuring absorbance at a wavelength of 490 nm on a 
microplate reader (Thermolab System, Franklin, MA). Total cellular 
LDH  was  determined  by  lysing  the  cells  with  1% Triton  X-100 
(high control); the assay medium served as a low control and was 
subtracted from all absorbance measurements:
Cytotoxicity (%) = (Experimental value – Low control) x 100%  
   
  (High control – Low control)
Dihydrorhodamine 123 (DHR) detection. The scavenging effect 
of sesamin against MPP+-induced oxidative stress was evaluated by 
DHR assay, as described previously.31,32 In brief, a stock solution 
of DHR (Molecular Probes, Eugene, OR) was prepared in dimeth-
ylsulfoxide (DMSO) to a concentration of 10 mM, deoxygenated 
with nitrogen and stored at -80˚C. Neuronal PC12 cells were treated 
with DMSO (Ctrl), sesamin and/or MPP+. Then, they were quickly 
washed with PBS 0.1 M and exposed to 250 µl of DHR at 37˚C for 
20 min. The slides were immediately examined under an Orthoplan 
fluorescence microscope (Leica, Wetzlar, Germany), photographed 
with a Qimaging camera (Nikon, Mississauga, ON, Canada) and 
analyzed by NIS-Element 2.2 software (Nikon).
Detection  of  SOD  and  CAT  activity.  Neuronal  cells  were 
mechanically  harvested  and  then  collected  by  centrifugation  at 
2,000g for 10 min at 4˚C. The pellets were homogenized in 1 ml 
of cold 20 mM HEPES buffer, pH 7.2 (1 mM EGTA, 210 mM 
mannitol and 70 mM sucrose) and sonicated (3 times, 5 s). The 
samples were then centrifuged at 1,500g for 5 min at 4˚C, and the 
supernatant was assayed according to the manufacturer’s protocol 
(Superoxide Dismutase Assay Kit or Catalase Assay Kit, Cayman 
Chemical, Ann Arbor, MI). One unit of SOD activity is defined 
as the amount of enzyme needed to exhibit 50% dismutation of 
superoxide radicals. The reaction was monitored at 450 nm with a 
microplate reader (Thermolab System). 
Electrophoresis  and  immunoblot  analysis.  NGF-differentiated 
PC12 cells were grown and treated in collagen-coated 6-well plates. 
Total cellular proteins were extracted with Nuclear Extraction Kit 
(Active  Motif,  Carlsbad,  CA),  diluted  in  50  μl  of  lysis  solution, 
and  their  concentration  determined  with  a  BCA  Protein  Assay 
Kit (Pierce, Rockford, IL). Equal amounts of protein (1 μg) were 
loaded onto 10% polyacrylamide gel-sodium dodecyl sulfate. After 
electrophoretic separation (180 volts, 45 min), the polyacrylamide 
gels were transferred onto nylon PVDF membranes (0.22-μm pore 
size, BioRad, Hercules, CA) at 60 V for 2 h. The membranes were 
blocked with 5% non-fat powder milk for 1 h at room tempera-
ture (RT). Immunoblotting was performed overnight at 4˚C with 
anti-TH  antibody  (1:2,000)  (Sigma),  anti-DAT  antibody  (1:50) Neuroprotective effects of sesamin
www.landesbioscience.com             Oxidative Medicine and Cellular Longevity   61
  17.  Shahidi F, Wanasundara PK. Phenolic antioxidants. Crit Rev Food Sci Nutr 1992; 32:67-
103.
  18.  Hirata F, Fujita K, Ishikura Y, Hosoda K, Ishikawa T, Nakamura H. Hypocholesterolemic 
effect of sesame lignan in humans. Atherosclerosis 1996; 122:135-36.
  19.  Lee CC, Chen PR, Lin S, Tsai SC, Wang BW, Chen WW, Tsai CE, Shyu KG. Sesamin 
induces nitric oxide and decreases endothelin-1 production in HUVECs: possible implica-
tions for its antihypertensive effect. J Hypertens 2004; 22:2329-38.
  20.  Noguchi T, Ikeda K, Sasaki Y, Yamamoto J, Seki J, Yamagata K, Nara Y, Hara H, Kakuta H, 
Yamori Y. Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in 
stroke-prone spontaneously hypertensive rats. Hypertens Res 2001; 24:735-42.
  21.  Nakano D, Kwak CJ, Fujii K, Ikemura K, Satake A, Ohkita M, Takaoka M, Ono Y, Nakai 
M, Tomimori N, Kiso Y, Matsumura Y. Sesamin metabolites induce an endothelial nitric 
oxide-dependent vasorelaxation through their antioxidative property-independent mecha-
nisms: possible involvement of the metabolites in the antihypertensive effect of sesamin. J 
Pharmacol Exp Ther 2006; 318:328-35.
  22.  Kiso Y. Antioxidative roles of sesamin, a functional lignan in sesame seed, and it’s effect on 
lipid- and alcohol-metabolism in the liver: a DNA microarray study. BioFactors (Oxford, 
England) 2004; 21:191-6.
  23.  Fujikawa T, Kanada N, Shimada A, Ogata M, Suzuki I, Hayashi I, Nakashima K. Effect 
of sesamin in Acanthopanax senticosus HARMS on behavioral dysfunction in rotenone-
induced parkinsonian rats. Biol Pharm Bull 2005; 28:169-72.
  24.  Jeng  KC,  Hou  RC,  Wang  JC,  Ping  LI.  Sesamin  inhibits  lipopolysaccharide-induced 
cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear 
factor-kappaB. Immunol Lett 2005; 97:101-6.
  25.  Gelinas S, Martinoli MG. Neuroprotective effect of estradiol and phytoestrogens on MPP+-
induced cytotoxicity in neuronal PC12 cells. J Neurosci Res 2002; 70:90-6.
  26.  Gagne B, Gelinas S, Bureau G, Lagace B, Ramassamy C, Chiasson K, Valastro B, Martinoli 
MG. Effects of estradiol, phytoestrogens, and Ginkgo biloba extracts against 1-methyl-4-
phenyl-pyridine-induced oxidative stress. Endocrine 2003; 21:89-95.
  27.  Miwa H, Kubo T, Morita S, Nakanishi I, Kondo T. Oxidative stress and microglial activa-
tion in substantia nigra following striatal MPP+. Neuroreport 2004; 15:1039-44.
  28.  Henze C, Hartmann A, Lescot T, Hirsch EC, Michel PP. Proliferation of microglial cells 
induced  by  1-methyl-4-phenylpyridinium  in  mesencephalic  cultures  results  from  an 
astrocyte-dependent mechanism: role of granulocyte macrophage colony-stimulating factor. 
J Neurochem 2005; 95:1069-77.
  29.  Martin A, Clynes M. Acid phosphatase: endpoint for in vitro toxicity tests. In Vitro Cell 
Dev Biol 1991; 27A:183-4.
  30.  Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of 
lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis 
factor (TNF) activity. J Immunol Meth 1988; 115:61-9.
  31.  Gelinas S, Bureau G, Valastro B, Massicotte G, Cicchetti F, Chiasson K, Gagne B, Blanchet 
J, Martinoli MG. Alpha and beta estradiol protect neuronal but not native PC12 cells from 
paraquat-induced oxidative stress. Neurotox Res 2004; 6:141-8.
  32.  Frantseva MV, Carlen PL, Perez Velazquez JL. Dynamics of intracellular calcium and free 
radical  production  during  ischemia  in  pyramidal  neurons.  Free  Radic  Biol  Med  2001; 
31:1216-27.
  33.  Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of 
multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034.
  34.  Henderson LM, Chappell JB. Dihydrorhodamine 123: a fluorescent probe for superoxide 
generation? Eur J Biochem 1993; 217:973-80.
  35.  Kooy NW, Royall JA, Ischiropoulos H, Beckman JS. Peroxynitrite-mediated oxidation of 
dihydrorhodamine 123. Free Radic Biol Med 1994; 16:149-56.
  36.  Thomas B, Saravanan KS, Mohanakumar KP. In vitro and in vivo evidences that antioxidant 
action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and 
monoamine oxidase-B inhibitor, 7-nitroindazole. Neurochem Int 2008; 52:990-1001.
  37.  Cheng YH, Ding ST, Chang MH. Effect of fumonisins on macrophage immune functions 
and gene expression of cytokines in broilers. Arch Anim Nutr 2006; 60:267-76.
  38.  Galati G, Sabzevari O, Wilson JX, O’Brien PJ. Prooxidant activity and cellular effects of the 
phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology 2002; 177:91-
104.
  39.  Anekonda TS. Resveratrol  —A boon for treating Alzheimer’s disease? Brain Res Rev 2006; 
52:316-26.
  40.  Hartman RE, Shah A, Fagan AM, Schwetye KE, Parsadanian M, Schulman RN, Finn 
MB, Holtzman DM. Pomegranate juice decreases amyloid load and improves behavior in a 
mouse model of Alzheimer’s disease. Neurobiol Dis 2006; 24:506-15.
  41.  Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, 
Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, 
Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, 
Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival 
of mice on a high-calorie diet. Nature 2006; 444:337-42.
  42.  Chiasson K, Daoust B, Levesque D, Martinoli MG. Dopamine D2 agonists, bromocrip-
tine and quinpirole, increase MPP+ -induced toxicity in PC12 cells. Neurotox Res 2006; 
10:31-42.
  43.  Kadota T, Yamaai T, Saito Y, Akita Y, Kawashima S, Moroi K, Inagaki N, Kadota K. 
Expression  of  dopamine  transporter  at  the  tips  of  growing  neurites  of  PC12  cells.  J 
Histochem Cytochem 1996; 44:989-96.
where E was the reaction efficiency, and ‘slope’ was the slope of the 
line generated in efficiency plots. All PCR efficiencies were above 
90%. In all PCR experiments, post-PCR DNA-melting curve anal-
ysis was undertaken to assess amplification specificity. DNA-melting 
was carried out at a temperature ramping rate of 1°C per step with 
1-s rest at each step. Relative gene transcription was calculated by the 
comparative Ct method, using the real-time efficiency values of each 
gene. cDNA levels among the samples were normalized by the expres-
sion level of 2 internal control genes: ubiquitin and β-microglobulin. 
These housekeeping genes were chosen with the GeNORM algo-
rithm.33 A normalization factor was calculated with the geometric 
mean of the 2 reference genes. The normalized expression of each 
gene of interest was calculated by dividing the raw quantities for each 
sample by the appropriate normalization factor.33
Statistical  analysis.  Significant  differences  between  treatment 
effects were determined by 1-way ANOVA, followed by Tukey’s post-
hoc  test  and  Student-Newman-Keuls  analysis  with  the  GraphPad 
Instat program, version 3.06, for Windows© (San Diego, CA, www.
graphpad.com). Data are expressed as the means ± S.E.M. from 3–15 
independent experiments. Asterisks (*) indicate statistical differences 
between the treatment and respective control conditions, and circles 
(o)  show  statistical  differences  between  the  treatment  and  MPP+ 
conditions. 
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